Skip to content
Friday 14 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,754.94
-0.16%
DAX
26,439.16
+0.53%
CAC 40
8,646.88
-0.04%
STOXX 50
6,555.12
+0.15%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Wednesday 02 December 2020 5:38 pm  |  Updated:  Wednesday 02 December 2020 5:53 pm

Pfizer vaccine to be rolled out across 50 hospital hubs from next week

By: Poppy Wood

Add as a preferred source on Google

Around 50 hospital hubs around England will start offering the Pfizer vaccine to patients and staff in care homes from next week, the chief executive of the NHS has announced.

Speaking at this evening’s Downing Street press conference, Simon Stephens said the NHS would also start sending letters out next week inviting vulnerable members of the population to go and get a vaccine from a designated hospital. 

The Pfizer/Biontech vaccine, which comes in packs of 975 doses, will first be given to the most vulnerable Brits, going down the generational chart. 

“In the subsequent weeks GP practices [will] come together in each area to operate local vaccination centres, and that will grow to over 1,000 places right across England,” Stephens added.

Stephens’ comments came after Prime Minister Boris Johnson praised the “biological jiu jitsu” of the Pfizer/Biontech coronavirus vaccine, adding that it provided the “sure and certain” knowledge that the UK will return to normality by the spring. 

“It is almost a year since humanity has been tormented by Covid,” said the PM. .

“All the time we’ve been waiting and hoping for the day where the searlights of science would pick out our invisible enemy… And today we can announce that the government has accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve the Pfizer/Biontech vaccine”.

However, Johnson warned Britain not to take its foot off the pedal in tackling the pandemic, telling the public that the “immense logistical challenges” in distributing the vaccine underlined the necessity for current restrictions. 

It comes after the UK recorded a further 648 coronavirus-related deaths in the past 24 hours, bringing the official number of Covid fatalities since the start of the pandemic to 59,699.

Read more

Ignore Palantir’s political opponents and look at the data: this technology helps patients

NHS logo on a white surface with visible water droplets, blue and white branding

Deputy chief medical officer Jonathan Van-Tam said he felt “very emotional” this morning at the “momentous journey” the world has experienced over the past year.

“Everyone needs to be delighted with the news today, but equally patient and realistic about how this rolls out over the next few months”, he said.

“The train has now stopped in the station and the doors have opened,” Van-Tam, who is no stranger to transport analogies, added. “This train is going to stop several times on the way. It’s going to have to reach all parts of the UK. There will be trains that come behind it, and it’s going to take time”.

Van-Tam also praised the determination and scientific ingenuity of Ugur Sahin and Ozlem Tureci, the Turkish-German couple behind Biontech.

However, he cautioned that while phase one of the vaccine rollout would likely stamp out 99 per cent of Covid deaths, the virus would be here to stay well into the future.

“I don’t think we’re going to eradicate coronavirus forever, it’s going to be with humankind forever,” he said.

Health secretary Matt Hancock earlier today announced he has given the green-light to 800,000 doses of the Pfizer vaccine to be rolled out from next week.

The government has spread its bets across 377m orders of seven different vaccines, including 40m doses of the Pfizer vaccine — enough to vaccinate 20m people in across Britain.

However, focus remains on the Astrzeneca/University of Oxford vaccine, which the UK has banked on by ordering 100m doses. The drugs company last week submitted its vaccine for approval to the MHRA, with a result expected in the next few days.

Read more

NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics

Related Topics

  • Boris Johnson
  • Coronavirus
  • Vaccine

Trending Articles

  • Revolut takes flight with launch of new airport lounges

  • Grandparents fund university degrees to avoid inheritance tax net

  • It’s not just Jason Arday, most of sociology is a scam

  • IT consultant ordered to pay £50,000 after being accused of stealing Soho House members’ personal details

  • Brompton Bicycle sues former adviser for ‘professional negligence’

More from Morning Wire

  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • New Victoria Hospital Goes Live with MEDITECH Expanse to Deliver New Era of Care

    Business Wire
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
  • Royal Hospital Chelsea to host top Arabian horse competition

    Sport Business
    British soldiers in red uniforms parade in front of historic buildings under a partly cloudy sky.
  • Mead Johnson Welcomes Defense Verdict in Collins Case

    Business Wire
  • Kemi Badenoch: AI firms ‘won’t come here’ if Britain overregulates

    Tech
    Kemi Badenoch discussing strategies for a stronger economy at a business conference podium, emphasizing economic growth
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook